Dị ka International Agency for Research on Cancer of the World Health Organisation si kwuo, na 2020, China nwere ihe dị ka nde 4.57 ọrịa cancer ọhụrụ, yana ọrịa cancer akpa ume na-aza ihe ruru 820,000.Dabere na "Ntuziaka maka nyocha ọrịa cancer akpa ume na mmalite nchọpụta na ọgwụgwọ na China" National Cancer Center nke China, ọnụọgụ na ọnụ ọgụgụ ọnwụ nke ọrịa cancer akpa ume na China ruru 37% na 39.8% nke ọnụ ọgụgụ zuru ụwa ọnụ, n'otu n'otu.Ọnụọgụ ndị a karịrị oke ọnụ ọgụgụ ndị China, nke bụ ihe dịka 18% nke ọnụ ọgụgụ ụwa.
Nkọwa naỤdị sub-ụdịnke ọrịa cancer akpa ume
Nkọwa:Ọrịa kansa akpa ume bronchogenic nke mbụ, nke a na-akpọkarị kansa dị ka ọrịa kansa akpa ume, bụ etuto ahụ kachasị njọ nke sitere na trachea, mucosa nke bronchi, obere bronchi ma ọ bụ glands na ngụgụ.
Dabere na njirimara histopathological, Enwere ike kewaa ọrịa cancer akpa ume n'ime ọrịa cancer akpa ume na-abụghị obere cell (80%-85%) na obere ọrịa cancer akpa ume (15%-20%), nke nwere ọkwa dị elu nke njọ.Ọrịa cancer akpa ume na-abụghị obere cell gụnyere adenocarcinoma, squamous cell carcinoma, na nnukwu cell carcinoma.
Dabere na ebe ihe mere, enwere ike ekewakwa ọrịa cancer akpa ume dị ka ọrịa cancer akpa ume etiti na ọrịa cancer akpa ume.
Ihe nchọpụta pathological nke ọrịa cancer akpa ume
Central Lung Cancer:Na-ezo aka na ọrịa kansa akpa ume na-esite na bronchi dị n'elu ọkwa nke akụkụ, nke bụ isi nweresquamous cell carcinoma na obere cell akpa ume cancer. Enwere ike nweta nchoputa nke pathological site na bronchoscopy fiber.Ịwa ahụ nke ọrịa cancer akpa ume etiti bụ ihe ịma aka, ma na-ejedebe na nhazigharị nke ngụgụ niile metụtara.Ndị ọrịa nwere ike isiri ike ịnagide usoro ahụ, na n'ihi ọkwa dị elu, mbuso agha mpaghara, mediastinal lymph node metastasis, na ihe ndị ọzọ, nsonaazụ ịwa ahụ nwere ike ọ gaghị adị mma, na-enwe nnukwu ihe ize ndụ nke metastasis ọkpụkpụ.
Ọrịa cancer akpa ume:Na-ezo aka na ọrịa cancer akpa ume na-eme n'okpuru akụkụ nke bronchi,Nke mbụ gụnyere adenocarcinoma. A na-enweta nchoputa nke pathological site na biopsy percutaneous transthoracic agịga nke CT na-eduzi.Na omume ụlọ ọgwụ, ọrịa cancer akpa ume na-adịkarị asymptomatic n'oge mmalite, a na-achọpụtakwa ya na mberede n'oge nyocha anụ ahụ.Ọ bụrụ na achọpụtara ya n'oge, ịwa ahụ bụ nhọrọ ọgwụgwọ bụ isi, yana adjuvant chemotherapy ma ọ bụ ọgwụgwọ ezubere iche na-esote.
Maka ndị ọrịa cancer akpa ume na-erughị eru maka ịwa ahụ, nwee nchoputa nke pathological nke chọrọ ọgwụgwọ na-esote, ma ọ bụ chọọ nlekọta ma ọ bụ ọgwụgwọ mgbe niile mgbe ịwachara ahụ,ọgwụgwọ ahaziri ahazi na nke kwesịrị ekwesị dị oke mkpa.Ọ ga-amasị anyị iwebata gịDr. An Tongtong, Ọkachamara ama ama na oncology thoracic nwere ahụmịhe karịrị afọ 20 na oncology ahụike na Ngalaba Thoracic Oncology, Hospitallọ Ọgwụ Mahadum Beijing.
Ọkachamara ama ama: Dr. An Tongtong
Onye dibia bekee, Dọkịta nke ọgwụ.Site na ahụmịhe nyocha na MD Anderson Cancer Center na United States, yana onye otu kọmitii ntorobịa nke kọmitii ọkachamara na-ahụ maka ọrịa kansa nke China Anti-Cancer Association Lung Cancer.
Mpaghara nka:Chemotherapy na ọgwụgwọ ezubere iche nke mkpụrụ ndụ maka ọrịa kansa akpa ume, thymoma, mesothelioma, na usoro nyocha na ọgwụgwọ dịka bronchoscopy na ịwa ahụ thoracic na-enyere vidiyo aka na ọgwụ ime.
Dr. An emeela nchọpụta miri emi na nhazi nhazi na ọgwụgwọ multidisciplinary zuru oke nke ọrịa cancer akpa ume dị elu,karịsịa n'ihe gbasara ọgwụgwọ zuru oke nke onwe onye maka ọrịa cancer akpa ume na-abụghị obere cell.Dr. An maara nke ọma na usoro nyocha na ọgwụgwọ nke mba ụwa kachasị ọhụrụ maka etuto thoracic.N'oge nyocha, Dr. An n'ụzọ zuru ezu na-aghọta akụkọ ahụike nke onye ọrịa ma na-enyocha mgbanwe nke ọrịa ahụ ka oge na-aga.Ọ na-ajụkwa nke ọma banyere nchọpụta nchọpụta na atụmatụ ọgwụgwọ gara aga iji hụ na nhazi oge nke atụmatụ ọgwụgwọ kachasị mma maka onye ọrịa.Maka ndị ọrịa a chọpụtara ọhụrụ, akụkọ na nyocha ndị metụtara ya anaghị ezughị oke.Mgbe ọ nwetasịrị nghọta doro anya banyere akụkọ ahụike ahụike, Dr. An ga-akọwara onye ọrịa ahụ na ndị ezinụlọ ha n'ụzọ doro anya usoro ọgwụgwọ maka ọnọdụ dị ugbu a.Ọ ga-enyekwa nduzi nke achọrọ nyocha ndị ọzọ iji nyere aka kwado nchoputa ahụ, hụ na ndị òtù ezinụlọ ghọtara nke ọma tupu ha ekwe ka ha na onye ọrịa ahụ jiri udo nke obi pụọ n'ọnụ ụlọ ndụmọdụ.
Ikpe nso nso a
Maazị Wang, onye ọrịa adenocarcinoma dị afọ 59 nwere ọtụtụ metastases sistemu, chọrọ ọgwụgwọ na Beijing n'oge ọrịa na-efe efe na ngwụcha 2022. N'ihi mmachi njem n'oge ahụ, ọ ga-anata usoro ọgwụgwọ mbụ ya na mpaghara dị nso. ụlọ ọgwụ mgbe achọpụtara ọrịa pathological.Agbanyeghị, Maazị Wang nwetara nnukwu nsi nke chemotherapy na ọnọdụ anụ ahụ adịghị mma n'ihi hypoalbuminemia concomitant.
N'ịbịaru nso usoro ọgwụgwọ chemotherapy nke abụọ ya, ezinụlọ ya, na-eche banyere ọnọdụ ya, jụrụ ajụjụ banyere ọkachamara Dr. An ma mesịa nwee ihe ịga nke ọma n'ịgba oge na VIP Outpatient Service nke Ụlọ Ọgwụ anyị.Mgbe nyochachara akụkọ ahụike zuru ezu, Dr. An nyere ndụmọdụ ọgwụgwọ.N'iburu n'uche ọkwa albumin dị ala nke Mr. Wang na mmeghachi omume chemotherapy, Dr. An gbanwere usoro ọgwụgwọ chemotherapy site na dochie paclitaxel na pemetrexed mgbe ọ na-etinye bisphosphonates iji gbochie mmebi ọkpụkpụ.
Mgbe ọ natara nsonaazụ ule mkpụrụ ndụ ihe nketa, Dr. An n'ihu dakọtara Mr. Wang na usoro ọgwụgwọ ezubere iche kwesịrị ekwesị, Osimertinib.Ọnwa abụọ ka e mesịrị, n'oge nleta na-esochi ya, ezinụlọ Maazị Wang kọrọ na ọnọdụ ya adịla mma, na-ebelata mgbaàmà na ikike ime ihe omume ndị dị ka ịga ije, ịgbara osisi mmiri, na ịsa ala n'ụlọ.Dabere na nsonaazụ nyocha nke nleba anya, Dr. An dụrụ Maazị Wang ọdụ ka ọ gaa n'ihu na usoro ọgwụgwọ ugbu a ma na-enyocha nyocha mgbe niile.
Oge nzipu: Ọgọst-31-2023